98 related articles for article (PubMed ID: 25867859)
21. Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts.
Hashiguchi D; Fukushima H; Nakamura M; Morikawa K; Yasuda H; Udagawa N; Maki K; Jimi E
J Biomed Mater Res A; 2011 Feb; 96(2):358-64. PubMed ID: 21171155
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
[TBL] [Abstract][Full Text] [Related]
23. Osteoclast differentiation in cocultures of a clonal chondrogenic cell line and mouse bone marrow cells.
Taylor LM; Turksen K; Aubin JE; Heersche JN
Endocrinology; 1993 Nov; 133(5):2292-300. PubMed ID: 7691585
[TBL] [Abstract][Full Text] [Related]
24. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
[TBL] [Abstract][Full Text] [Related]
25. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
26. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
27. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
28. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
29. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
31. The influence of proepicardial cells on the osteogenic potential of marrow stromal cells in a three-dimensional tubular scaffold.
Valarmathi MT; Yost MJ; Goodwin RL; Potts JD
Biomaterials; 2008 May; 29(14):2203-16. PubMed ID: 18289664
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling.
Ryu J; Kim HJ; Chang EJ; Huang H; Banno Y; Kim HH
EMBO J; 2006 Dec; 25(24):5840-51. PubMed ID: 17124500
[TBL] [Abstract][Full Text] [Related]
33. Sol-gel bioactive glasses support both osteoblast and osteoclast formation from human bone marrow cells.
Karpov M; Laczka M; Leboy PS; Osyczka AM
J Biomed Mater Res A; 2008 Mar; 84(3):718-26. PubMed ID: 17635026
[TBL] [Abstract][Full Text] [Related]
34. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J
Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577
[TBL] [Abstract][Full Text] [Related]
35. Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes.
Clabaut A; Delplace S; Chauveau C; Hardouin P; Broux O
Differentiation; 2010 Jul; 80(1):40-5. PubMed ID: 20466479
[TBL] [Abstract][Full Text] [Related]
36. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
37. Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation.
Yang L; Hai Y; Zhou JL
Chin Med J (Engl); 2011 Jul; 124(13):2033-7. PubMed ID: 22088466
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
39. [Comparison between MLO-Y4 osteocyte and osteoblast to support osteoclast formation in vitro].
Cui L; Li XT; Yang YQ; Fu MK; Zhang D
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Jul; 45(7):411-5. PubMed ID: 21122433
[TBL] [Abstract][Full Text] [Related]
40. Wear particles and surface topographies are modulators of osteoclastogenesis in vitro.
Sommer B; Felix R; Sprecher C; Leunig M; Ganz R; Hofstetter W
J Biomed Mater Res A; 2005 Jan; 72(1):67-76. PubMed ID: 15536650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
